Abstract
The emergence and spread of drug-resistant parasites poses a major problem for management of Plasmodium falciparum malaria in endemic areas. Nowhere is this more apparent than in southeast Asia, where multi-drug resistance to chloroquine and sulfadoxine-pyrimethamine was exacerbated when mefloquine monotherapy began failing in the 1980s. A better understanding of mechanisms of (multi-) drug resistance is urgently warranted to monitor and guide antimalarial chemotherapy regimens more efficiently. Here we review recent advances on identification of molecular markers that can be employed in predicting in vitro and in vivo resistance in southeast Asia. Examples include amplification of PfMDR1 (P. falciparum multi-drug resistant gene 1) and mefloquine, K76T PfCRT and chloroquine, as well as mutations in the dihydroperoate synthase and dihydrofolate reductase genes and the antifolate class of drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adagu IS, Dias F, Pinheiro L, Rombo L, do Rosario V, Warhurst DC (1996) Guinea Bissau: association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug-resistance gene PfMDR1. Trans R Soc TropMed Hyg 90:90–91
Adagu IS, Warhurst DC (1999a) Allele-specific, nested, one tube PCR: application to PfMDR1 polymorphisms in Plasmodium falciparum. Parasitology 119:1–6
Adagu IS, Warhurst DC (1999b) Association of cg2 and PfMDR1 genotype with chloroquine resistance in field samples of Plasmodium falciparum from Nigeria. Parasitology 119:343–348
Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N et al. (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363: 9–17
Anderson TJ (2004) Mapping drug resistance genes in Plasmodium falciparum by genome-wide association. Curr Drug Targets Infect Disord 4:65–78
Anderson TJ, Nair S, Williams JT, Brockman A, Paiphun L, Newton PN, Mayxay M, Guthmann J-P, Simithuis FM, Hien TT, Van den Broek I, Nosten F (2003) Population structure revealed by selected and putatively neutral SNPs in S.E. Asian malaria parasites. American Society of Tropical Medicine and Hygiene, Atlanta
Attaran A, Barnes KI, Curtis C, d’Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape JF, Watkins WM (2004) WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363:237–240
Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D (2001) High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene PfCRT and the multidrug resistance Gene PfMDR1. J Infect Dis 183:1535–1538
Berens N, Schwoebel B, Jordan S, Vanisaveth V, Phetsouvanh R, Christophel EM, Phompida S, Jelinek T (2003) Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR. Trop Med Int Health 8:775–782
Borrmann S, Binder RK, Adegnika AA, Missinou MA, Issifou S, Ramharter M, Wernsdorfer WH, Kremsner PG (2002) Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. Trans R Soc Trop Med Hyg 96:660–663
Chongsuphajaisiddhi T, Sabchareon A (1981) Sulfadoxine-pyrimethamine resistant falciparum malaria in Thai children. Southeast Asian J Trop Med Public Health 12:418–421
Cowman AF, Galatis D, Thompson JK (1994) Selection for mefloquine resistance in Plasmodium falciaprum is linked to amplification of the PfMDR1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 91:1143–1147
Cowman AF, Karcz S, Galatis D, Culvenor JG (1991) A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol 113:1033–1042
Cowman AF, Lew AM (1989) Antifolate drug selection results in duplication and rearrangement of chromosome 7 in Plasmodium chabaudi. Mol Cell Biol 9:5182–5188
Cowman AF, Lew AM (1990) Chromosomal rearrangements and point mutations in the DHFR-TS gene of Plasmodium chabaudi under antifolate selection.Mol Biochem Parasitol 42:21–29
Desjardins RE, Canfield CJ et al. (1979) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16:710–718
Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV Coulibaly D (2001) A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344:257–263
Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O’Neill PM, Bray PG, Ward SA, Krishna S (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424:957–961
Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6:861–871
Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF (1990) Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255–258
Foote SJ, Thompson JK, Cowman AF, Kemp DJ (1989) Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57:921–930
Grobusch MP, Adagu IS, Kremsner PG, Warhurst DC (1998) Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of PfMDR1 Asn86Tyr polymorphism in Lambarene, Gabon. Parasitology 116:211–217
Hunt P, Cravo PV, Donleavy P, Carlton JM, Walliker D (2004) Chloroquine resistance in Plasmodium chabaudi: are chloroquine-resistance transporter (crt) and multidrug resistance (mdr1) orthologues involved? Mol Biochem Parasitol 133:27–35
Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White NJ, Suh E, Beerli P, Su XZ (2003) Early origin and recent expansion of Plasmodium falciparum. Science 300:318–321
Kamchonwongpaisan S, Chandra-ngam G, et al. (1994) Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting α-thalassemic erythrocytes in vitro. J Clin Invest 93:467–473
Kremsner PG, Krishna S (2004) Combination chemotherapy. Lancet 364:438–447
Krishna S, Planche T, Agbenyega T, Woodrow C, Agranoff D, Bedu-Addo G, Owusu-Ofori AK, Appiah JA, Ramanathan S, Mansor SM, Navaratnam V (2001) Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother 45:509–516
Krishna S, White NJ (1996) Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinetics 30:263–299
Luxemberger C, Perea WA, Delmas G, Pruja C, Pecoul B, Moren A (1994) Permethrin-impregnated bed nets for the prevention of malaria in schoolchildren on the Thai-Burmese border. Trans R Soc Trop Med Hygiene 88:155–159
Marzolini C, Paus E, Buchlin T, Kim RB (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75:13–33
Mawili-Mboumba DP, Kun JF et al. (2002) PfMDR1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients. Antimicrob Agents Chemother 46:166–170
Moreno A, Brasseur P et al. (2001) Evaluation under field conditions of the colourimetric DELI-microtest for the assessment of Plasmodium falciparum drug resistance. Trans R Soc Trop Med Hyg 95:100–103
Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Hien TT, White NJ, Nosten F, Anderson TJ (2003) A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Mol Biol Evol 20:1526–1536
Ngo T, Duraisingh M, Reed M, Hipgrave D, Biggs B, Cowman AF (2003) Analysis of PfCRT, PfMDR1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. Am J Trop Med Hyg 68:350–356
Noedl H, Wernsdorfer WH et al. (2002) Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother 46:1658–1664
Nomura T, Carlton JM, Baird JK, del Portillo HA, Fryauff DJ, Rathore D, Fidock DA, Su X, Collins WE, McCutchan TF, Wootton JC, Wellems TE (2001) Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis 183:1653–1661
Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ (1991a) Mefloquine-resistant falciparum malaria on the Thai—Burmese border. Lancet 337:1140–1143
Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Na Banchang K, Karbwang J, White NJ (1991b) Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria. Br J Clin Pharmacol 31:556–559
Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ (2000). Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356:297–302
Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick SR (2003). Resistance to antimalarials in Southeast Asia and genetic polymorphisms in PfMDR1. Antimicrob Agents Chemother 47:2418–2423
Pillai DR, Labbe AC et al. (2001). Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis 183:789–795
Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems T (1995) Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hygiene 52:656–568
Price R, Robinson G, Brockman A, Cowman A, Krishna S (1997) Assessment of PfMDR1 gene copy number by tandem competitive polymerase chain reaction. Mol Biochem Parasitol 85:161–169
Price R, Uhlemann A-C, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White N, Nosten F, Krishna S (2004) Mefloquine resistance in Plasmodium falciparum results from increased PfMDR1 gene copy number. Lancet 364:438–447
Price RN, Cassar C, et al. (1999) The PfMDR1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother 43:2943–2949
Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S (1997a) Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 91:574–577
Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi T, White NJ (1997b) Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 91:574–577
Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF (2000) PgH1 modulates sensitivity and reisstance ot multiple antimalarials in Plasmodium falciparum. Nature 403:906–909
Schwenke A, Brandts C, Philipps J, Winkler S, Wernsdorfer WH, Kremsner PG (2001) Declining chloroquine resistance of Plasmodium falciparum in Lambarene, Gabon from 1992 to 1998.Wien KlinWochenschr 113:63–64
Sidhu AB, Verdier-Pinard D, Fidock DA (2002) Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by PfCRT mutations. Science 298:210–213
Silamut K, White NJ et al. (1985) Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg 34:681–686
Srivastava IK, Morrisey JM, Darrouzet E, Daldal F, Vaidya AB (1999) Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol Microbiol 33:704–711
Tinto H, Ouedraogo JB, Erhart A, Van Overmeir C, Dujardin JC, Van Marck E, Guiguemde TR, D’Alessandro U (2003) Relationship between the PfCRT T76 and the PfMDR1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. Infect Genet Evol 3:287–292
Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, Farrar J (2004) Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 363:18–22
Trape JF, Pison G, Preziosi MP, Enel C, Desgrees du Lou A, Delaunay V, Samb B, Lagarde E, Molez JF, Simondon F (1998) Impact of chloroquine resistance on malaria mortality. C R Acad Sci III 321:689–697
Wang P, Sims PF et al. (1997) A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance. Parasitology 115:223–230
Wellems TE (1991) Molecular genetics of drug resistance in Plasmodium falciparum malaria. Parasitol Today 7:110–112
Wellems TE, Plowe CV (2001) Chloroquine-resistant malaria. J Infect Dis 184:770–776
Wellems TE, Walker-Jonah A, Panton LJ (1991) Genetic mapping of the chloroquine resistance locus on Plasmodium falciparum chromosome 7. Proc Natl Acad Sci USA 88:3382–3386
White NJ (1992) Antimalarial drug resistance: the pace quickens. J Antimicrobial Chemother 30:571–585
Wichmann O, Betschart B et al. (2003) Prophylaxis failure due to probable mefloquine resistant P falciparum from Tanzania. Acta Trop 86:63–65
Wilson CM, Serrano AE et al. (1989) Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244:1184–1186
Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ (2002) Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320–323
Yuvaniyama J, Chitnumsub P, Kamchongwongpaisan S, Vanichtanankul J, Sirawaraporn W, Taylor P, Walkinshaw MD, Yuthavong Y (2003) Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol 10: 357–365
Zucker JR, Ruebush TK 2nd, Obonyo C, Otieno J, Campbell CC (2003) The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. Am J Trop Med Hyg 68:386–390
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Uhlemann, AC., Krishna, S. (2005). Antimalarial Multi-Drug Resistance in Asia: Mechanisms and Assessment. In: Compans, R.W., et al. Malaria: Drugs, Disease and Post-genomic Biology. Current Topics in Microbiology and Immunology, vol 295. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29088-5_2
Download citation
DOI: https://doi.org/10.1007/3-540-29088-5_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25363-1
Online ISBN: 978-3-540-29088-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)